Recent Finacing
Recent Raise
Biofidelity develops and commercializes ASPYRE molecular diagnostic assays that run on standard PCR instruments to rapidly and sensitively detect genomic biomarkers for NSCLC and other cancers with simplified workflows.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
See the team members at Biofidelity.
